N02AE01 - Buprenorphine |
Not porphyrinogenic |
NP |
Rationale
Substrate of CYP 3A4. Inhibitor os CYPs 3A4, 2D6, 1A1, 1A2, 2B6, 2C19, 2C8, 2C9, 2E1. Several references consider it safe. Significant clinical experience points to non-porphyrinogenicity.
Chemical description
Partial opioid antagonist used in postoperative pain and in Sweden also repeatedly in acute porphyric crises. Metabolized by CYP 3A4. MFM James, RJ Hift. Porphyrias. Br J Anaesth 2000; 85, 143-53: use EPI-list: safe Australian list: safe. South African list: use French list: use Without adverse reaction frequently used during acute porphyric crises (Sweden).
IPNet drug reports
Uneventful use reported in 6 patients with acute porphyria.
Similar drugs
References
Tradenames
Buprenorfine · BuTrans · Temgesic · Transtec 
Temgesic · Temgesic Sublingualis · Transtec 
Buprenorfina · Buprex · Feliben · Gexana · Transtec 
Busetalt · Busette · Durlevatec · Septrapat · Temgesic · Transtec 
Buprenorphin · Temgesic · Transtec 
Bunov · Bupeaze · Buplast · Bupramyl · Buprenorphine · Busiete · Butec · BuTrans · Buvidal · Carlosafine · Gabup · Hapoctasin · Natzon · Panitaz · Prefibin · Prenotrix · Rebrikel · Reletrans · Relevtec · Sevodyne · Subutex · Temgesic · Tephine · Transtec · Turgeon 
Buprefarm · Bupremyl · Buprenorphin · Buprenorphine · BuTrans · Norspan · Norvipren · Subutex · Temgesic 
Bugnanto · Buprefarm · Buprenorphine · Norspan · Temgesic 
Bunondol · Bunorfin · Melodyn · Transtec 
Butrans 
Buprenorphin · Temgesic · Temgesic Sublingualis · Transtec 
Buprenorphine · Norspan 
Buprefarm · Bupremyl · Buprenorphine · Norspan · Temgesic 
Norspan 
Norspan 
Transtec 
Addnok · Buprenorfin · Transtec · Triquisic